Global Artificial Pancreas Device System (APDS) Market Growth (Status and Outlook) 2024-2030

Global Artificial Pancreas Device System (APDS) Market Growth (Status and Outlook) 2024-2030

According to our LPI (LP Information) latest study, the global Artificial Pancreas Device System (APDS) market size was valued at US$ 70 million in 2023. With growing demand in downstream market, the Artificial Pancreas Device System (APDS) is forecast to a readjusted size of US$ 159.8 million by 2030 with a CAGR of 12.6% during review period.

The research report highlights the growth potential of the global Artificial Pancreas Device System (APDS) market. Artificial Pancreas Device System (APDS) are expected to show stable growth in the future market. However, product differentiation, reducing costs, and supply chain optimization remain crucial for the widespread adoption of Artificial Pancreas Device System (APDS). Market players need to invest in research and development, forge strategic partnerships, and align their offerings with evolving consumer preferences to capitalize on the immense opportunities presented by the Artificial Pancreas Device System (APDS) market.

The Artificial Pancreas Device System is a system of devices that closely mimics the glucose regulating function of a healthy pancreas.

Most Artificial Pancreas Device Systems consists of three types of devices already familiar to many people with diabetes: a continuous glucose monitoring system (CGM) and an insulin infusion pump. A blood glucose device (such as a glucose meter) is used to calibrate the CGM.

A computer-controlled algorithm connects the CGM and insulin infusion pump to allow continuous communication between the two devices. Sometimes an artificial pancreas device system is referred to as a "closed-loop" system, an "automated insulin delivery" system, or an "autonomous system for glycemic control."

An Artificial Pancreas Device System will not only monitors glucose levels in the body but also automatically adjusts the delivery of insulin to reduce high blood glucose levels (hyperglycemia) and minimize the incidence of low blood glucose (hypoglycemia) with little or no input from the patient.

The classification of artificial pancreas devices systems includes threshold suspended device systems and hybrid closed-loop APDS, and the proportion of artificial pancreas devices systems in 2017 is about 60%, and the proportion is in decreasing trend from 2013 to 2017.

Artificial pancreas devices systems are widely used in hospital and clinic. The most proportion of artificial pancreas devices systems is in hospital, and the proportion in 2017 is about 59%.

North America is the largest consumption place, with a consumption market share nearly 54% in 2017. Following North America, Europe is the second largest consumption place with the consumption market share of 35%.

Market competition is intense. Medtronic is the leader of the industry, and it holds key technologies and patents, with high-end customers; has been formed in the monopoly position in the industry.

Key Features:

The report on Artificial Pancreas Device System (APDS) market reflects various aspects and provide valuable insights into the industry.

Market Size and Growth: The research report provide an overview of the current size and growth of the Artificial Pancreas Device System (APDS) market. It may include historical data, market segmentation by Type (e.g., Threshold Suspended Device Systems, Hybrid Closed-loop APDS), and regional breakdowns.

Market Drivers and Challenges: The report can identify and analyse the factors driving the growth of the Artificial Pancreas Device System (APDS) market, such as government regulations, environmental concerns, technological advancements, and changing consumer preferences. It can also highlight the challenges faced by the industry, including infrastructure limitations, range anxiety, and high upfront costs.

Competitive Landscape: The research report provides analysis of the competitive landscape within the Artificial Pancreas Device System (APDS) market. It includes profiles of key players, their market share, strategies, and product offerings. The report can also highlight emerging players and their potential impact on the market.

Technological Developments: The research report can delve into the latest technological developments in the Artificial Pancreas Device System (APDS) industry. This include advancements in Artificial Pancreas Device System (APDS) technology, Artificial Pancreas Device System (APDS) new entrants, Artificial Pancreas Device System (APDS) new investment, and other innovations that are shaping the future of Artificial Pancreas Device System (APDS).

Downstream Procumbent Preference: The report can shed light on customer procumbent behaviour and adoption trends in the Artificial Pancreas Device System (APDS) market. It includes factors influencing customer ' purchasing decisions, preferences for Artificial Pancreas Device System (APDS) product.

Government Policies and Incentives: The research report analyse the impact of government policies and incentives on the Artificial Pancreas Device System (APDS) market. This may include an assessment of regulatory frameworks, subsidies, tax incentives, and other measures aimed at promoting Artificial Pancreas Device System (APDS) market. The report also evaluates the effectiveness of these policies in driving market growth.

Environmental Impact and Sustainability: The research report assess the environmental impact and sustainability aspects of the Artificial Pancreas Device System (APDS) market.

Market Forecasts and Future Outlook: Based on the analysis conducted, the research report provide market forecasts and outlook for the Artificial Pancreas Device System (APDS) industry. This includes projections of market size, growth rates, regional trends, and predictions on technological advancements and policy developments.

Recommendations and Opportunities: The report conclude with recommendations for industry stakeholders, policymakers, and investors. It highlights potential opportunities for market players to capitalize on emerging trends, overcome challenges, and contribute to the growth and development of the Artificial Pancreas Device System (APDS) market.

Market Segmentation:

Artificial Pancreas Device System (APDS) market is split by Type and by Application. For the period 2019-2030, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of value.

Segmentation by type
Threshold Suspended Device Systems
Hybrid Closed-loop APDS
Other Systems

Segmentation by application
Hospitals
Clinics

This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
Medtronic
Bigfoot Biomedical
Beta Bionics
Admetsys
Insulet
Tandem Diabetes Care
Defymed

Please note: The report will take approximately 2 business days to prepare and deliver.